183 related articles for article (PubMed ID: 16797284)
41. Multi-drug resistance gene-1 (MDR-1) haplotypes and the CYP3A5*1 genotype have no influence on ciclosporin dose requirements as assessed by C0 or C2 measurements.
Fredericks S; Jorga A; MacPhee IA; Reboux S; Shiferaw E; Moreton M; Carter ND; Holt DW; Johnston A
Clin Transplant; 2007; 21(2):252-7. PubMed ID: 17425754
[TBL] [Abstract][Full Text] [Related]
42. Effect of the ABCB1 3435C>T polymorphism on tacrolimus concentrations and dosage requirements in liver transplant recipients.
Bonhomme-Faivre L; Picard V; Saliba F; Abbara C; Fodil M; Chaunoy M; Farinotti R
Am J Health Syst Pharm; 2009 Sep; 66(18):1645-51. PubMed ID: 19729569
[TBL] [Abstract][Full Text] [Related]
43. Pharmacodynamic monitoring of the conversion of cyclosporine to tacrolimus in heart and lung transplant recipients.
Barten MJ; Rahmel A; Garbade J; Bold A; Bittner HB; Dhein S; Mohr FW; Gummert JF
Transplant Proc; 2005 Dec; 37(10):4532-4. PubMed ID: 16387162
[TBL] [Abstract][Full Text] [Related]
44. Pharmacogenotyping of CYP3A5 in predicting dose-adjusted trough levels of tacrolimus among Malaysian kidney-transplant patients.
Hamzah S; Teh LK; Siew JS; Ahmad G; Wong HS; Zakaria ZA; Salleh MZ
Can J Physiol Pharmacol; 2014 Jan; 92(1):50-7. PubMed ID: 24383873
[TBL] [Abstract][Full Text] [Related]
45. Do drug transporter (ABCB1) SNPs and P-glycoprotein function influence cyclosporine and macrolides exposure in renal transplant patients? Results of the pharmacogenomic substudy within the symphony study.
Llaudó I; Colom H; Giménez-Bonafé P; Torras J; Caldés A; Sarrias M; Cruzado JM; Oppenheimer F; Sánchez-Plumed J; Gentil MÁ; Ekberg H; Grinyó JM; Lloberas N
Transpl Int; 2013 Feb; 26(2):177-86. PubMed ID: 23216707
[TBL] [Abstract][Full Text] [Related]
46. CYP3A5 *1 allele: impacts on early acute rejection and graft function in tacrolimus-based renal transplant recipients.
Min SI; Kim SY; Ahn SH; Min SK; Kim SH; Kim YS; Moon KC; Oh JM; Kim SJ; Ha J
Transplantation; 2010 Dec; 90(12):1394-400. PubMed ID: 21076384
[TBL] [Abstract][Full Text] [Related]
47. ABCB1 C3435T genetic polymorphism on population pharmacokinetics of methotrexate after hematopoietic stem cell transplantation in Korean patients: a prospective analysis.
Kim IW; Yun HY; Choi B; Han N; Park SY; Lee ES; Oh JM
Clin Ther; 2012 Aug; 34(8):1816-26. PubMed ID: 22796246
[TBL] [Abstract][Full Text] [Related]
48. [Relationship between MDR1 gene polymorphism and blood concentration of tacrolimus in renal transplant patients].
Wang W; Zhang XD; Ma LL; Lü YP; Hu XP; Zhang P; Wang Y; Guan DL
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3277-81. PubMed ID: 16409819
[TBL] [Abstract][Full Text] [Related]
49. Genotype and allele frequencies of MDR1 gene C1236T polymorphism in a Turkish population.
Gümüş-Akay G; Rüstemoğlu A; Karadağ A; Sunguroğlu A
Genet Mol Res; 2008 Oct; 7(4):1193-9. PubMed ID: 19048498
[TBL] [Abstract][Full Text] [Related]
50. Influence of pharmacogenetic polymorphisms in routine immunosuppression therapy after renal transplantation.
Herrero MJ; Sánchez-Plumed J; Galiana M; Bea S; Marqués MR; Aliño SF
Transplant Proc; 2010 Oct; 42(8):3134-6. PubMed ID: 20970628
[TBL] [Abstract][Full Text] [Related]
51. ABCB1 gene polymorphisms are not associated with treatment outcome in elderly acute myeloid leukemia patients.
van der Holt B; Van den Heuvel-Eibrink MM; Van Schaik RH; van der Heiden IP; Wiemer EA; Vossebeld PJ; Löwenberg B; Sonneveld P
Clin Pharmacol Ther; 2006 Nov; 80(5):427-39. PubMed ID: 17112800
[TBL] [Abstract][Full Text] [Related]
52. Effect of atorvastatin therapy and conversion to tacrolimus on hypercholesterolemia and endothelial dysfunction after renal transplantation.
Wissing KM; Unger P; Ghisdal L; Broeders N; Berkenboom G; Carpentier Y; Abramowicz D
Transplantation; 2006 Sep; 82(6):771-8. PubMed ID: 17006324
[TBL] [Abstract][Full Text] [Related]
53. MDR1 gene polymorphisms and clinical relevance.
Li YH; Wang YH; Li Y; Yang L
Yi Chuan Xue Bao; 2006 Feb; 33(2):93-104. PubMed ID: 16529292
[TBL] [Abstract][Full Text] [Related]
54. Intestinal MDR1/ABCB1 level at surgery as a risk factor of acute cellular rejection in living-donor liver transplant patients.
Masuda S; Goto M; Fukatsu S; Uesugi M; Ogura Y; Oike F; Kiuchi T; Takada Y; Tanaka K; Inui K
Clin Pharmacol Ther; 2006 Jan; 79(1):90-102. PubMed ID: 16413244
[TBL] [Abstract][Full Text] [Related]
55. ABCB1 single-nucleotide polymorphisms determine tacrolimus response in patients with ulcerative colitis.
Herrlinger KR; Koc H; Winter S; Teml A; Stange EF; Fellermann K; Fritz P; Schwab M; Schaeffeler E
Clin Pharmacol Ther; 2011 Mar; 89(3):422-8. PubMed ID: 21289623
[TBL] [Abstract][Full Text] [Related]
56. The donor ABCB1 (MDR-1) C3435T polymorphism is a determinant of the graft glomerular filtration rate among tacrolimus treated kidney transplanted patients.
Tavira B; Gómez J; Díaz-Corte C; Coronel D; Lopez-Larrea C; Suarez B; Coto E
J Hum Genet; 2015 May; 60(5):273-6. PubMed ID: 25673014
[TBL] [Abstract][Full Text] [Related]
57. Pharmacokinetic study of the combination of tacrolimus and fluconazole in renal transplant patients.
Lumlertgul D; Noppakun K; Rojanasthien N; Kanchanarattanakorn K; Jittikanont S; Manoyot A; Bunnachak D; Ophascharoensuk V
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S73-8. PubMed ID: 17044457
[TBL] [Abstract][Full Text] [Related]
58. Influence of ABCB1 genetic polymorphisms on cyclosporine intracellular concentration in transplant recipients.
Crettol S; Venetz JP; Fontana M; Aubert JD; Ansermot N; Fathi M; Pascual M; Eap CB
Pharmacogenet Genomics; 2008 Apr; 18(4):307-15. PubMed ID: 18334915
[TBL] [Abstract][Full Text] [Related]
59. CYP3A5 and ABCB1 polymorphisms influence tacrolimus concentrations in peripheral blood mononuclear cells after renal transplantation.
Capron A; Mourad M; De Meyer M; De Pauw L; Eddour DC; Latinne D; Elens L; Haufroid V; Wallemacq P
Pharmacogenomics; 2010 May; 11(5):703-14. PubMed ID: 20415563
[TBL] [Abstract][Full Text] [Related]
60. The Effect of ABCB1 Polymorphisms on Serial Tacrolimus Concentrations in Stable Austrian Long-Term Kidney Transplant Recipients.
Riegersperger M; Plischke M; Steinhauser C; Jallitsch-Halper A; Sengoelge G; Winkelmayer WC; Sunder-Plassmann G; Födinger M
Clin Lab; 2016 Oct; 62(10):1965-1972. PubMed ID: 28164520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
